A detailed history of Guggenheim Capital LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Guggenheim Capital LLC holds 155,849 shares of RPRX stock, worth $3.91 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
155,849
Previous 150,985 3.22%
Holding current value
$3.91 Million
Previous $3.98 Million 10.73%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$25.63 - $29.27 $124,664 - $142,369
4,864 Added 3.22%
155,849 $4.41 Million
Q2 2024

Aug 14, 2024

BUY
$26.26 - $29.9 $716,792 - $816,150
27,296 Added 22.07%
150,985 $3.98 Million
Q1 2024

May 14, 2024

BUY
$27.46 - $31.33 $607,936 - $693,614
22,139 Added 21.8%
123,689 $3.76 Million
Q4 2023

Feb 14, 2024

SELL
$26.21 - $29.22 $809,338 - $902,284
-30,879 Reduced 23.32%
101,550 $2.85 Million
Q3 2023

Nov 14, 2023

BUY
$26.26 - $31.38 $557,237 - $665,883
21,220 Added 19.08%
132,429 $3.59 Million
Q2 2023

Aug 11, 2023

BUY
$29.6 - $36.56 $10,508 - $12,978
355 Added 0.32%
111,209 $3.42 Million
Q1 2023

May 10, 2023

SELL
$32.77 - $39.4 $516,487 - $620,983
-15,761 Reduced 12.45%
110,854 $3.99 Million
Q4 2022

Feb 14, 2023

BUY
$39.17 - $44.04 $1.21 Million - $1.36 Million
30,977 Added 32.39%
126,615 $5 Million
Q3 2022

Nov 14, 2022

SELL
$39.88 - $44.65 $1.01 Million - $1.14 Million
-25,420 Reduced 21.0%
95,638 $3.84 Million
Q2 2022

Aug 15, 2022

SELL
$37.53 - $44.22 $370,571 - $436,628
-9,874 Reduced 7.54%
121,058 $5.09 Million
Q1 2022

May 16, 2022

SELL
$37.46 - $42.44 $514,438 - $582,828
-13,733 Reduced 9.49%
130,932 $5.1 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $895,990 - $1.08 Million
25,476 Added 21.37%
144,665 $5.77 Million
Q3 2021

Nov 15, 2021

BUY
$36.14 - $42.24 $3.98 Million - $4.65 Million
110,123 Added 1214.68%
119,189 $4.31 Million
Q2 2021

Aug 13, 2021

BUY
$39.85 - $46.63 $361,280 - $422,747
9,066 New
9,066 $372,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.